New York § 3220 Findings

New York Statutes

§ 3220 — Findings

New York § 3220

Law PBHPublic Health

Art. 32-ARecombinant Dna Experiments

This text of New York § 3220 (Findings) is published on Counsel Stack Legal Research, covering New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

N.Y. Public Health § 3220 (2026).

Text

  § 3220. Findings.  The legislature finds that new techniques of\ngenetic manipulation which allow researchers to accomplish exchanges of\ngenetic material between unlike organisms offer great potential for\nexpanding human knowledge of genetics but also may present significant\nrisks to public health, to the environment and to the health of research\nworkers.  These experiments are being conducted at research institutions\nin New York, including universities, hospitals and industrial\nfacilities. Industry plans to mass-produce recombinant organisms should\nsuch organisms be found to have commercial uses.  Such research and\nproduction should only be conducted under safe conditions as prescribed\nby the commissioner.\n

Free access — add to your briefcase to read the full text and ask questions with AI

§ 3220. Findings. The legislature finds that new techniques of\ngenetic manipulation which allow researchers to accomplish exchanges of\ngenetic material between unlike organisms offer great potential for\nexpanding human knowledge of genetics but also may present significant\nrisks to public health, to the environment and to the health of research\nworkers. These experiments are being conducted at research institutions\nin New York, including universities, hospitals and industrial\nfacilities. Industry plans to mass-produce recombinant organisms should\nsuch organisms be found to have commercial uses. Such research and\nproduction should only be conducted under safe conditions as prescribed\nby the commissioner.\n